FDA Inspection
Daiichi Sankyo Chemical Pharma Co., Ltd.Daiichi Sankyo Chemical Pharma Co., Ltd. – FDA Inspection, Dec 22, 2023
Record Details
This FDA Inspection record concerns Daiichi Sankyo Chemical Pharma Co., Ltd., with an inspection on December 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 56a2c626-2e61-41ea-b358-8e6ed18c4d79
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1226353
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daiichi Sankyo Chemical Pharma Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 2, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Daiichi Sankyo Chemical Pharma Co., Ltd.
- FDA Inspection 1080814 - 2019-01-18
- FDA Inspection 934436 - 2015-07-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.